Le macrophage dans la fibrose pulmonaire idiopathique : effets du nintédanib et expression du biomarqueur pronostique CXCL13

Nessrine Bellamri(Inserm)
ORI-OAI warehouse (University of Rennes)
December 18, 2019
Cited by 0

Related Papers

Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
|International Immunopharmacology|2019|63
Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis
|International Immunopharmacology|2023|26
Macrophage in idiopathic pulmonary fibrosis : effets of Nintedanib and expression of the prognostic biomarker CXCL13
|theses.fr (ABES)|2019|0